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in any medium, provided the original work is properly citeMiner1 is a redox-active 2Fe2S cluster protein. Mutations in Miner1 result in
Wolfram Syndrome, a metabolic disease associated with diabetes, blindness,
deafness, and a shortened lifespan. Embryonic fibroblasts from Miner1/ mice
displayed ER stress and showed hallmarks of the unfolded protein response. In
addition, loss of Miner1 caused a depletion of ER Ca2þ stores, a dramatic increase
in mitochondrial Ca2þ load, increased reactive oxygen and nitrogen species, an
increase in the GSSG/GSH and NADþ/NADH ratios, and an increase in the ADP/ATP
ratio consistent with enhanced ATP utilization. Furthermore, mitochondria in
fibroblasts lackingMiner1 displayed ultrastructural alterations, such as increased
cristae density and punctate morphology, and an increase in O2 consumption.
Treatment with the sulphydryl anti-oxidant N-acetylcysteine reversed the
abnormalities in the Miner1 deficient cells, suggesting that sulphydryl reducing
agents should be explored as a treatment for this rare genetic disease.a, San Diego, La Jolla,
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Wolfram Syndrome (DIDMOAD) is an incurable disease
characterized by a range of endocrine and neurological
symptoms, including diabetes insipidus, diabetes mellitus,
blindness due to optic atrophy and sensorineural deafness.
Wolfram Syndrome is also associated with an increased
incidence of psychiatric disorders and a significantly shortened
life span, averaging only 30 years (Barrett et al, 1995; Strom
et al, 1998). Two unrelated genes have been shown to be
mutated in Wolfram Syndrome (Amr et al, 2007; Sam et al,
2001). These genes, originally designated as WFS1 and WFS2,
have since been demonstrated to encode the Wolframin and
Miner1 proteins.
Mutations in Wolframin (WFS1), the first gene linked to
Wolfram Syndrome, are responsible for the majority ofWolfram
Syndrome cases. Recently, single nucleotide polymorphisms
(SNPs) of the WFS1 gene have also been implicated in the
pathogenesis of type 2 diabetes (Wasson & Permutt, 2008).is an open access article under
se, distribution and reproduction
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www.embomolmed.org Research Article
Sandra E. Wiley et al.WFS1 encodes a 100 kDa integral membrane protein of the ER
that lacks known catalytic domains (Hofmann, 2003). Although
there is some evidence that WFS1 is involved in Ca2þ
homeostasis and influences the stability of the ER stress sensor
ATF6 (Fonseca et al, 2010; Osman, 2003; Takei et al, 2006), the
exact function of WFS1, its regulation, and the molecular
mechanisms linking its function to Wolfram Syndrome and
type 2 diabetes are far from resolved.
WFS2 encodes the Miner1 protein (aka: ERIS, CISD2). We
previously identified a small family of proteins with high
sequence similarity that includes mitoNEET, Miner1 andMiner2
(Wiley et al, 2007a). The current names for the genes encoding
these proteins are CISD (CDGSH Iron Sulphur Domain) 1, 2 and
3, respectively. CDGSH domains are characterized by the
presence of a Cys-Asp-Gly-Ser-His motif. MitoNEET and Miner1
each contain a single carboxy-terminal CDGSH domain, while
Miner2 possesses tandem CDGSH domains. In addition to the
CDGSH domain, there is a predicted hydrophobic sequence at
the amino-terminus of Miner1. The CDGSH domain binds a
redox active 2Fe2S cluster that is coordinated by an uncommon
arrangement of 3 Cys and 1 His (Wiley et al, 2007b). The
structures of the CDGSH domains of mitoNEET and Miner1 are
virtually identical (Conlan et al, 2009; Paddock et al, 2007).
The molecules exist as dimers with a unique fold. The His
that ligates the 2Fe2S cluster is surface exposed and exquisitely
sensitive to protonation if the pH is less than 7.0, resulting
in release of the 2Fe2S cluster, a unique property among
FeS cluster-binding proteins. This feature has led to the
speculation that this family of proteins may be involved in
FeS cluster assembly or their mobilization within the cell;
alternatively, it may function in a redox capacity, as has been
found for other 2Fe2S cluster proteins. Our initial data suggested
that Miner1 with a C-terminal EGFP tag localized to the ER
(Wiley et al, 2007a). However, a recent study concluded that
Miner1 is predominantly a mitochondrial protein (Chen et al,
2009).
In an effort to locate a previously mapped longevity gene
linked to human chromosome 4q (Puca et al, 2001), Tsai and
colleagues generated mice in which the Miner1 (Cisd2) gene is
deleted (Chen et al, 2009). These mice have a complex and
dramatic phenotype and, indeed, appear to be a remarkable
model of early aging, in addition to recapitulating many of the
features ofWolfram Syndrome.Within 3 weeks after birth, pups
lacking Miner1 show signs of optic and sciatic nerve atrophy.
These mice develop normally for a short period and then
proceed to display sarcopenia, thinning of the subcutaneous
fat, hair loss, hair greying, osteopenia, lordokyphosis and
significantly shortened lifespan. Although Cisd2 KO mice are
not overtly diabetic, their glucose tolerance is impaired.
Our understanding of the biological function of CDGSH
domain proteins is still in its infancy. The phenotype of the Cisd2
KO mice suggests that Miner1 is crucial for the maintenance of
multiple organ systems throughout the body, including the
pancreas, skin, musculoskeletal and nervous systems. Miner1
appears to be at the nexus of metabolism and lifespan control.
Insights into the functions of Miner1 will not only provide
knowledge regarding the etiology of Wolfram Syndrome, butEMBO Mol Med (2013) 5, 904–918 should also shed light on an important new regulatory protein
linking metabolic disease and aging.
Given the importance of ER/mitochondrial interactions
to metabolic regulation, we have used mouse embryonic
fibroblasts (MEFs) derived from Miner1 WT and KO mice
to investigate the role of Miner1 in maintaining proper ER
function and ER-mitochondrial communication. Miner1 KO
cells displayed a dramatic reduction in ER Ca2þ and profound
mitochondrial Ca2þ loading. Although mitochondrial respira-
tory capacity was increased in the KO cells, there was an
increase in the ADP/ATP ratio and impaired cell proliferation.
Miner1 deficient cells also displayed signs of oxidative stress
and initiation of the unfolded protein response (UPR).
Remarkably, treatment with the anti-oxidant N-acetylcysteine
(NAC) reversed many of the molecular abnormalities caused by
Miner1 deletion. Current treatments for Wolfram Syndrome
focus on managing the diabetic symptoms; however, none of
these reverse the degenerative course of the disease. Our data
suggest that a potential therapeutic approach utilizing sulphy-
dryl anti-oxidants, such as NAC, could more effectively target
the underlying cause of the disease.RESULTS
Miner1 is an integral membrane protein that localizes to the
ER and MAMs facing the cytosol
The conflicting conclusions regarding the localization of Miner1
(ER versus mitochondria) may stem from the considerable
physical contact between the mitochondria and the ER (Pizzo
& Pozzan, 2007). Mitochondria-associated ER membranes
(MAMs) consist of ER and mitochondrial proteins and represent
regions of direct physical contact between the two organelles,
typically rich in proteins involved in Ca2þ signalling and lipid
biosynthesis (Osman et al, 2011; Zampese et al, 2011).
Because the ER, mitochondria and MAMs perform very
distinct functions, defining the exact localization of Miner1
within the cell is an important and necessary first step towards
understanding its role in Wolfram Syndrome.
To this end, we isolated microsomal (ER) fractions, MAMs
and mitochondria from rat livers and evaluated them by
Western blotting with antibodies recognizing marker proteins to
the various fractions: Miner1, ER (calnexin), MAM (FACL4),
cytosol (tubulin) and mitochondria (Complex I 8 kDa protein).
Our data revealed that Miner1 was most abundant in the
ER-enriched fractions and was not detected in highly purified
mitochondria (MP) (Fig 1A). It is noteworthy that there was a
substantial amount of Miner1 present in the MAM fraction. To
confirm the ER localization, we used fluorescence microscopy.
C-terminally taggedMiner1-EGFP displayed a strong perinuclear
localization that extended into a lacy reticulum present
throughout the cell (Fig 1B). This pattern is typical of ER
proteins such as calreticulin (Fig 1B). We have previously
reported that Miner1 does not colocalize with the mitochondrial
marker MitoTracker Red (Wiley et al, 2007a). A triple staining of
cells with Miner1-EGFP, an ER marker and MitoTracker Red
further demonstrates the positive co-localization of Miner12013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 905
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Figure 1. Miner1 is an ER and MAM integral membrane protein facing the cytosol. Source data is available for this figure in the Supporting Information.
A. Western blot analysis of rat liver subcellular fractions (30mg protein per lane), immunoblotted with antibodies to marker proteins: mitochondrial (mitoNEET
and Complex I 8 kDa protein), ER (calnexin), MAMs (FACL4), cytosolic/soluble proteins (tubulin), H¼post-nuclear homogenate; MC¼ crude mitochondria;
MP¼ pure mitochondria; ER¼ endoplasmic reticulum; MAM¼mitochondrial associated ER membranes; C¼ cytosol.
B. Immunofluorescent imaging of transiently transfected COS-7 cells expressing Miner1-EGFP (green), costained with anti-calreticulin (red). These are shown in
black and white. In the merged pseudocolored image, the co-localized portion appears yellow. Scale bar is 10mm.
C. Western blot analysis of rat liver ER microsomes after treatment with either high salt (200mM KCl) or alkaline (0.1M Na2CO3, pH 11.5) to remove peripheral
membrane proteins. IRE1 (an integral membrane protein) and Bip (a peripheral membrane associated protein) were included as controls.
D. Western blot analysis of HEK293T cells transiently transfected with Miner1-EGFP. Microsomes were prepared and treated with trypsin 1% Triton X100
(TX100). The disappearance of theMiner1-EGFP fusion protein (46 kDa) was monitored using an antibody to GFP. IRE1 immunoreactivity was used as a control
for an integral ER protein oriented towards the cytosol, and PDI as a control for a protein present within the ER lumen.
906with the ER marker and lack of mitochondrial localization
(Supporting Information Figs S1, S2).
While we have clearly established that Miner1 localizes to
the ER, it remains unknown how it is anchored there and
whether the CDGSH domain is present in the ER lumen or
the cytoplasm. To distinguish integral from peripheral mem-
brane proteins, microsomes were subjected to high salt and
alkaline washes. Miner1 remained associated with microsomal
membranes under these conditions, as did the ER integral
membrane protein IRE1 (Fig 1C). This is in contrast to Bip, a
peripheral membrane-associated protein of the ER lumen. This
establishes Miner1 as an integral membrane protein of the ER,
which is consistent with the Octopus program predictions of a 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.transmembrane (TM) domain between amino acids 37–57 in
human Miner1 (Viklund & Elofsson, 2008). We performed
trypsinolysis on freshly prepared microsomes containing
Miner1-EGFP with a trypsin cleavage site in the linker region
between the two proteins. The integrity of the full-length
Miner1-EGFP protein was monitored by anti-GFP Western
blotting. In the absence of detergents, Miner1-EGFP was
susceptible to trypsinolysis, as was the IRE1 protein, an integral
ER membrane kinase with the bulk of the protein facing the
cytosol, in contrast to the luminal protein disulphide isomerase
(PDI) (Fig 1D). Taken together, our data define Miner1 as an
integral ER membrane protein with the CDGSH domain oriented
towards the cytosol.EMBO Mol Med (2013) 5, 904–918
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Sandra E. Wiley et al.Miner1 KO MEFs show signs of ER stress and UPR
Wolfram Syndrome has been linked to mutations in both WFS1
and CISD2 (Miner1). It has been reported that deletion of Wfs1
results in ER stress and the initiation of the UPR (Fonseca et al,
2010; Yamada, 2006). Thus, we hypothesized that deletion of the
Miner1 gene would also lead to an induction of the UPR and that
this is a common thread in the etiology of Wolfram Syndrome.
Taking advantage of the recent development of a Miner1
(Cisd2) KOmouse, we immortalized early passage primary MEF
cells from mutant embryos and WT littermates. There was no
detectable Miner1 protein in the KO MEFs (Fig 2A). However,
the abundance of mitoNEET, the related CDGSH family
protein localized to the outer mitochondrial membrane, was
markedly increased in the KO MEFs. This possibly represents
a compensatory upregulation, which might imply similar
functions for the CDGSH domains in these family members.
ER stress and UPR induction in Miner1 WT and KO MEFs were
investigated on multiple levels. There are three major signalling
arms of the UPR, which are mediated by the proteins PERK,
IRE1 and ATF6 (Oslowski & Urano, 2011). The mRNA levels of
the ER stress pathway proteins Bip (an IRE1 target gene) and
CHOP (a pro-apoptotic PERK target gene) were increased
significantly in Miner1 KO cells, compared with WT controls
(Fig 2B); Bip and CHOP protein levels also were increasedA
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Figure 2. Deletion of Miner1 leads to ER stress. Source data is available for th
A. Western blot analysis of whole cell lysates from wildtype (WT) and Miner1 k
B. qRT-PCR of the ER stress markers Bip (t-test, n¼6, p< 0.0001), CHOP (t-test
C. Western blot analysis of whole cell lysates from Miner1 WT and KO MEFs (15
D. Immunofluorescent staining of WT and KO MEFs using an anti-calreticulin (ER
small boxes (positioned over plasma membrane and subplasmalemmal area)
E. Electron micrographs of WT and KO MEFs revealing swollen ER in KO cells. Nor
images of WT and KO, respectively.
EMBO Mol Med (2013) 5, 904–918 (Fig 2C). The greater than 3-fold increase in Bip mRNA and the
5.5-fold increase in CHOP mRNA are comparable to or greater
than those reported for Wfs1 deficient islets, MIN6 and INS1
cells (Fonseca et al, 2005; Yamada, 2006). To query activation of
the ATF6 arm of the UPR, XBP1 gene expression was analysed,
revealing an increase in the Miner1 KO MEFs (Fig 2B). Thus,
Miner1 KO cells showed changes in gene and protein expression
consistent with activation of the UPR.
Another hallmark of cells undergoing ER stress and the UPR is
an expansion of the ER to increase the capacity to process the
accumulated unfolded proteins (Zheng et al, 2011). Immuno-
fluorescence staining of WT and KO cells using an antibody to
the ER protein calreticulin revealed that the KO cells were larger
and that they displayed an increase in the density of the reticular
staining pattern throughout the cell (Fig 2D), suggesting ER
expansion. Electron microscopy (EM) of the KO cells showed
areas of ER with what appeared to be a swollen lumen (Fig 2E).
Together, these data demonstrate that MEFs lacking the Miner1
protein do indeed show signs of ER stress/UPR, suggesting this
is a common feature in the development of Wolfram Syndrome.
Miner1 deletion results in dysregulation of Ca2R homeostasis
ER stress occurs when the demand for ER protein folding
exceeds the capacity. Because many ER chaperone proteins areC
Bip
CHOP
GAPDH
WT KO
HOP
KO
***
tXBP1
WT KO
0.0
0.5
1.0
1.5
2.0
2.5
**
E 
WT KO
*
*
*
is figure in the Supporting Information.
nockout (KO) MEFs (20mg protein).
, n¼ 6, p<0.0001), and total XBP1 (t-test, n¼3, p¼ 0.0013), mean SE.
mg protein).
, green) antibody and DAPI (nucleus, blue). Insets are 300% enlargements of
. Scale bars are 10mm.
mal versus distended portions of the ER are marked with a red asterisk in the
2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 907
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908Ca2þ dependent, alterations in the Ca2þ concentration of the ER
lumen can lead to ER stress (Eizirik et al, 2008). Given the ER
stress observed in the Miner1 KO MEFs, we used the Ca2þ
sensitive fluorescent dye Fura-2-AM to investigate whether a
lack of Miner1 protein leads to Ca2þ dysregulation. There was a
lower basal level of cytosolic Ca2þ in Miner1 KO cells, and
significantly less Ca2þ was released from the ER in response to
thapsigargin (Tg), an inhibitor of the ER sarco-endoplasmic
reticulum Ca2þ ATPase (SERCA) (Fig 3A). The peak response
(Max signal – basal) was 65% lower in the KO cells relative to
the WT (Fig 3B). These data are similar to the changes observed
in WFS1 knock down cells (Takei et al, 2006). The inositol
triphosphate (IP3) receptor is a major ER Ca
2þ efflux channel. To
assess agonist-induced Ca2þ release, cells were treated with
histamine to stimulate the production of IP3 and the opening of
IP3-dependent Ca
2þ channels. Interestingly, ER Ca2þ release in0 100 200
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Figure 3. Miner1 deletion results in dysregulation of Ca2R homeostasis.
A. Miner1 wildtype (WT) and knockout (KO) MEFs were treated with 2mM Tg to in
live cells using Fura2-AM. Mean SE of 6 replicates from a representative ex
B. Peak Ca2þ release (maximum minus basal) in WT and KO MEFs after 2mM T
Mean SE.
C. Ca2þ release in WT and KO MEFs via the IP3 receptor after treatment with 100
D. Quantification and distribution of intracellular Ca2þ pools in WT and KO MEF
(p<0.0001). KO mito>WT mito (p<0.0001). Inset shows mitochondrial Ca
Mean SE.
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.response to histamine was more profound in the KO than in WT
cells (Fig 3C), possibly indicating that the cells lacking Miner1
are primed for ER Ca2þ efflux.
In addition to the ER, mitochondria play a dominant role in
cellular Ca2þ handling. Mitochondria rapidly sequester Ca2þ via
the mitochondrial Ca2þ uniporter. The mitochondrial uptake
of ER-released Ca2þ is facilitated by the localization of the
ER Ca2þ efflux channels to sites where the ER and mitochondria
physically interact.
To test the model that Ca2þ released by the ER due to the
absence of Miner1 accumulates in the mitochondria, digitonin-
permeabilized Miner1 WT and KO MEFs were analysed
fluorimetrically using the Ca2þ-sensitive dye, Calcium Green
5N and agents that induce the release of Ca2þ from the
mitochondria (FCCP and antimycin A). Subsequently, the total
release of Ca2þ from all internal stores was achieved by theB
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Sandra E. Wiley et al.addition of alamethicin (Alm), followed by pulses of Ca2þ to
serve as an internal calibration curve (Supporting Information
Fig S3 and Methods). As predicted, there was a dramatic
increase in mitochondrial Ca2þ content in cells lacking Miner1
(Fig 3D and Supporting Information Fig S3). In fact, the total
cellular Ca2þ content, determined using Calcium Green and
Alm, in the Miner1 KO cells was 6.3-fold greater than in WT
cells, due primarily to this increase in mitochondrial load. Even
more striking was the alteration in the relative contribution of
the separate Ca2þ stores to the total pool. In WT cells, the
majority of the total Ca2þ measured was present in non-
mitochondrial pools, whereas in Miner1-deficient cells, the
mitochondrial Ca2þ pool represented 60% of the total (Fig 3D
inset). Our data establish Miner1 as a key determinant in
regulating not only ER, but also mitochondrial and total cellular
Ca2þ homeostasis.
Miner1 KO MEFs show altered mitochondrial function and
ultrastructure
The significant increase in mitochondrial Ca2þ loading seen in
Miner1 KO cells prompted us to investigate various aspects
of mitochondrial physiology. Several matrix dehydrogenases
are stimulated by Ca2þ. In particular, the pyruvate dehydro-
genase complex (PDH) is regulated by a Ca2þ-dependent
phosphatase that counteracts inhibitory phosphorylation on
the PDH E1a subunit. WT and Miner1-deficient cells were
analysed by Western blotting with phospho-specific antibodies
to two E1a phosphorylation sites on PDH, pSer 293 and pSer
300, whose phosphorylation is inversely correlated with activity
(Linn et al, 1969; Rardin et al, 2009). We observed a substantial
reduction in Ser 293 and Ser 300 phosphorylation in Miner1
KO cells (Fig 4A), consistent with the observed increase in the
Ca2þ levels in the mitochondrial matrix (Fig 3D) and possibly
substrate flux through PDH.
Immunofluorescence staining for the mitochondrial marker
cytochrome c revealed a similar reticular pattern in many WT
and Miner1 KO MEFs; however, the KO population had
more cells that displayed a punctate mitochondrial pattern
(Supporting Information Fig S4A). Given the elevated mito-
chondrial Ca2þ load and punctate morphology, we anticipated
that mitochondrial respiratory function might have been
compromised. Unexpectedly, when O2 consumption rates
(OCRs) were measured, Miner1 deficient MEFs displayed a
significantly higher OCR relative to WT MEFs, for both FCCP-
stimulated maximal rates, as well as basal rates of respiration
(Fig 4B). To determine if this reflected an increase in the amount
of mitochondria per cell, lysates were prepared from the same
number of cells from both KO and WT MEFs and analysed
for abundance of mitochondrial proteins. Although we did not
observe a general increase in the levels of mitochondrial
proteins in Miner1 KO cells, we did detect an increase in several
components of the electron transport chain (ETC) (Fig 4C). To
eliminate the complications inherent in monitoring whole cell
OCR in different cell populations in which mitochondrial mass
may differ, we isolated mitochondria from WT and Miner1 KO
MEFs and directly assayed O2 consumption using the Seahorse
XF24 instrument, following our published protocol (Rogers et al,EMBO Mol Med (2013) 5, 904–918 2011). As detected using whole cells, the OCR of isolated
mitochondria from Miner1-deficient MEFs was significantly
higher than that of WT cells (Fig 4D).
Despite the enhanced respiratory capacity, the ADP/ATP
ratio in the Miner1 KO cells was higher than in controls
(Supporting Information Fig S4B), and the DNA synthesis levels
in Miner1 KO cells were lower than in WT cells (Supporting
Information Fig S4C). The difference in OCR between the basal
rate and oligomycin-induced rate represents the amount of
oxygen consumption that is utilized for ATP production in the
cell (Brand & Nicholls, 2011). Although the rates of respiration
after addition of oligomycin were similar in both cell types
(indicating a similar level of proton leak), the magnitude of the
decrease in response to the ATP synthase inhibitor was much
greater in the KO cells (Fig 4B), which suggests enhanced ATP
utilization. The increased ADP/ATP ratio is also consistent with
an enhanced rate of ATP utilization. Together, these data
indicate that the mitochondria of Miner1-deficient cells have an
increase in maximal OCR, possibly associated with Ca2þ-
stimulated increase in substrate flux through PDH and the TCA
cycle, combined with an increase in ETC components per
mitochondria. Furthermore, the bioenergetics data suggest an
enhanced energy demand in the Miner1 KO cells.
Given the elevated Ca2þ load in the Miner1 KO cell
mitochondria, it was surprising that the mitochondria did not
appear damaged on a functional level. To analyse further the
structural integrity and abundance of the mitochondria, we
employed EM and morphometric analysis. Miner1 KO cells did
not contain an increased volume of mitochondria per cell
(Supporting Information Fig S4D), but the relative surface area
of mitochondrial cristae was increased (Fig 4E). Because ETC
complexes reside in the cristae of the IMM, the EM data are
consistent with the increased abundance of ETC components
detected by Western blot and the increased maximal
respiratory capacity. In addition, we observed increased
numbers of mitochondria containing extensions with either
very few or no cristae and small mitochondria devoid of cristae
in the Miner1 KO cells (Supporting Information Fig S4E–F),
possibly representing damaged mitochondria destined for
mitophagy.
Miner1 KO MEFs display higher levels of mitoNEET protein
relative to controls. Because mitoNEET is a bona fide
mitochondrial protein (Wiley et al, 2007a), it is conceivable
that the phenotype observed in the Miner1 KO MEFs was the
result of mitoNEET overexpression. To investigate this
possibility, we generated Miner1 WT and KO MEF cells with
a doxycycline-inducible mitoNEET shRNA (or luciferase shRNA
controls), as well as Miner1WTMEF cells stably overexpressing
mitoNEET to levels observed in Miner1 KO cells, and analysed
them for mitochondrial parameters and ER stress. Reduction of
mitoNEET protein in Miner1 KO MEFs had no effect on Bip or
CHOP mRNA levels, phosphorylation of PDH, nor mitochon-
drial morphology (Supporting Information Fig S5A–D). Like-
wise, overexpression of mitoNEET in Miner1 WT cells did not
result in significant changes in Bip or CHOP mRNA levels, PDH
phosphorylation or oxygen consumption rates (Supporting
Information Fig S6A–D). This data does not support a causative2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 909
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B. Representative Seahorse measurement of OCR (2 106 cells) of WT and KO MEFs.
C. Western blot analysis of whole cell lysates from WT and KO cells, loading based on equal cell numbers. Blots were probed with antibodies against various
mitochondrial proteins and Miner1. SMAC localizes to the mitochondrial intermembrane space. Inner membrane proteins included ETC components NDUFB6
(Complex I), CII 30 kDa protein (Complex II) and ATP synthase alpha subunit (Complex V).
D. Maximal FCCP-stimulated OCR of mitochondria purified from WT and KO MEFs. Either glutamate/malate or succinate/rotenone were offered as oxidizable
substrates (t-test, n¼ 4, p<0.0001 for each substrate pair). Mean SE.
E. Cristae abundance (cristae area/outer mitochondrial membrane area per mitochondrion) was increased in KO MEFs. Measurements were made frommultiple
EM micrographs (t-test, n¼20, p¼0.033). Mean SE.
910role for elevatedmitoNEET expression in the development of the
observed phenotype in the Miner1 KO MEFs.
It would appear that the loss of Miner1 at the ER creates
a situation that impinges on the mitochondria, likely as a
function of ER-mitochondrial communication and altered Ca2þ
homeostasis.
Lack of Miner1 leads to a more oxidized intracellular milieu
The only defined functional domain in the Miner1 protein is
the CDGSH domain, which binds a redox-active 2Fe-2S
cluster, leading to the speculation that Miner1 is involved in
redox regulation. To determine if Miner1 can affect the redox
status of the cell, we monitored a variety of redox-sensitive
processes. 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.Many redox reactions in the cell are coupled to the NADþ/
NADH redox pair. There was an increase in the NADþ/NADH
ratio (Fig 5A), indicative of a more oxidized milieu in the KO
cells. To detect levels of cellular ROS production in Miner1 WT
and KO MEFs, we utilized the cell-permeable indicator carboxy-
H2DCFDA. The fluorescence in WT cells was faint; however,
Miner1 KO cells exhibited a robust fluorescence signal (Fig 5B),
suggesting increased ROS production in the KO cells. NO levels
were imaged in live cells loadedwith the NO-specific fluorescent
dye NO-ON. Miner1 KO MEFs exhibited markedly increased
fluorescence compared with controls, indicating substantially
increased NO production (Fig 5C).We also used the Griess assay
to measure nitrite concentrations in the cell culture media.
In agreement with the results of live fluorescence imaging, theEMBO Mol Med (2013) 5, 904–918
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Figure 5. Shift towards oxidized environment in Miner1 KO cells.
A. NADþ/NADH ratios (normalized to WT) in wildtype (WT) and Miner1 knockout (KO) MEF lysates (t-test, n¼4, p<0.0001). Mean SE.
B. Live cell imaging at 20X magnification of WT and KO MEFs after labelling with the Image-iT LIVE Green ROS indicator and co-staining nuclei with DAPI (blue).
Intensity of green fluorescence is proportional to amount of ROS in cell. Dashed circles mark nuclei in WT.
C. Brightfield (left panels) and fluorescent (right panels) images of WT and KO MEFs at 10 magnification after labelling with NO–ON. Intensity of green
fluorescence is proportional to amount of NO in cell. Images were captured at identical camera settings for B and C. Graph at right reports Griess Assay
quantitation of NO2 in WT and KO MEF cell culture media (t-test, n¼4, p¼ 0.008). Mean SE.
D. Left panel is FluoroThiol assays withWT and KOMEF lysates to quantitate total reduced thiols per g of protein (t-test, n¼3, p¼ 0.0393). Right panel is graph of
GSH/GSSG ratios in WT and KO cells (t-test, n¼ 3, p¼0.0005). Mean SE.
E. Western blot analysis of WT and KO WCL with antibody to oxidized active site cysteine of PTPs.
F. Non-reducing SDS-PAGE and Western blots of SERCA2 immunoprecipitates from WT and KO whole cell lysates. PVDF membranes initially blotted with an
antibody to glutathione adducts on proteins (Glut), then stripped and probed for total SERCA2.Griess assay also suggested an increase in NO production in
Miner1-deficient MEFs (Fig 5C). Thus, Miner1 KO MEFs exhibit
multiple signs of reactive oxygen and nitrogen-mediated stress.
Many proteins critical to ER-mitochondrial signalling, such
as Ca2þ channels and phosphatases, have redox sensitiveEMBO Mol Med (2013) 5, 904–918 cysteines, whose oxidation state can regulate activity (Karisch
et al, 2011; Sammels et al, 2010; Tonks, 2006). In addition,
the oxidation status of the cysteine-containing tripeptide
glutathione, a major anti-oxidant in the cell, reflects the level
of oxidative stress (Biswas et al, 2006). To probe the general2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 911
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912oxidation state of total thiols in the cell, lysates fromWT and KO
MEFs were assayed using the redox-sensitive fluorescent dye,
Fluorothiol. Miner1 KO MEFs displayed a decrease in total
reduced thiols (Fig 5D), reflecting a shift towards a more
oxidized state of protein thiols. Direct measurement of oxidized
glutathione (GSH/GSSG) (after deproteination) also confirmed
the more oxidized status of KO MEFs (Fig 5D).
Members of the protein tyrosine phosphatase (PTP) CX5R
family play critical roles in signalling throughout the cell,
including in the ER and mitochondria. Dysfunction of several
members of this family have been implicated in both diabetes
and aging (Koren & Fantus, 2007; Wei et al, 2011). PTPs possess
an essential redox-sensitive cysteine in their active site that,
when oxidized, results in enzyme inactivation. This oxidation
can be reversible (sulphenic acid) or irreversible (sulphinic and
sulphonic acid). Because the oxidative shift in the Miner1 KO
cells was subtle, we specifically examined the oxidation state of
CX5R PTPs to determine if the oxidative stress in the KO cells
would be sufficient to affect the activity of this important class of
signalling molecules. WT and Miner1 KO MEFs were lysed in
degassed buffer containing reducing agents, cleared of insoluble
material and analysed by Western blotting with an antibody
specific to the sulphonic acid oxidation state of the catalytic
cysteine of many PTPs (OX-PTP). There was an increase in the
number of reactive bands in the Miner1 KO lysates. We also
investigated the oxidation state of specific PTPs using a recently
developed mass spectrometry technique (Karisch et al, 2011),
which also revealed an increase in PTP oxidation (expressed as
% oxidized, Supporting Information Table S1). The spectrum of
PTPs that were oxidized suggests that a number of different
signalling networks are likely to be affected in Miner1 deficient
cells.
The primary proteins mediating both ER Ca2þ influx (SERCA)
and efflux (IP3R and the ryanodine receptor, RYR) channels
contain redox-sensitive cysteines that affect channel activity
(Andersson et al, 2011; Sammels et al, 2010; Tong et al, 2010). In
addition to the cysteine oxidation states mentioned above,
redox-active cysteines in SERCA can be oxidatively modified
by adduction with glutathione (glutathionylated) in response
to elevated NO, which alters its activity. Oxidation of the
IP3 receptor and RyR channels are reported to increase their
channel activity, resulting in Ca2þ leak from the ER. SERCA2
immunoprecipitation, followed by anti-glutathione Western
blotting, revealed increased levels of glutathione adducts in the
KO cells (Fig 5F). These data suggest that cells lacking Miner1
display multiple signs of oxidative stress.
Anti-oxidant treatment reverses stresses induced by lack of
Miner1
As lack of Miner1 results in oxidative stress, we asked whether
anti-oxidant treatment might reverse the anomalies observed in
Miner1 KO MEFs. To test this possibility, WT and Miner1 KO
MEFs were treated for 48 h with anti-oxidants and evaluated for
ER stress responses andmitochondrial function. Treatment with
5mM NAC for 48 h resulted in an amelioration of many of the
anomalies detected in the Miner1 KO MEFs. There was virtually
none of the pro-apoptotic CHOP protein detected in NAC-treated 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.KO MEFs and a reduction in the amount of Bip protein (Fig 6A),
suggesting that the ER stress resulted from an oxidative stress.
Our data are consistent with a model of oxidative stress
inducing Ca2þ leak from the ER, which is sequestered into the
mitochondria, thereby stimulating dephosphorylation of PDH.
We used PDH phosphorylation as a surrogate monitor of
mitochondrial Ca2þ load. While pS293 was substantially
reduced relative to WT in the untreated KO cells, pS293-PDH
was returned to the levels observed in the WT cells after NAC
treatment (Fig 6B). We also examined mitochondrial homeo-
stasis at the level of morphology and function. NAC treatment
resulted in a return to a reticular morphology in the KO
mitochondria (Fig 6C). After NAC treatment, the increased
respiration rates observed in the KO cells were restored to levels
virtually the same as those in WT cells (Fig 6D). These
experiments strongly suggest that oxidative stress lies at the root
of the ER and mitochondrial changes caused by Miner1
deficiency, and importantly that sulphydryl anti-oxidant treat-
ment could be a rational therapeutic approach for treating this
syndrome.
Re-expression of Miner1 partially rescues the Miner1(/)
MEF phenotype
To support that the observed ER and mitochondrial changes in
the Miner1 KO cells was due to lack of Miner1 protein, we re-
expressed Miner1 protein in the Miner1(/) cells and probed
for reversal of the aberrant phenotype. Miner1 cDNA was
introduced into the KO cells using lentivirus transduction and
neomycin-resistant pools of cells (referred to as KO-M1þ cells)
were used to analyse ER and mitochondrial parameters. The
level of Miner1 exogenous expression obtained was substan-
tially less than in WT cells; however, it was sufficient to rescue
the mitochondrial parameters measured. PDH phosphorylation
in the KO-M1þ cells was similar to that in WT cells, as were
mitochondrial morphology, oxygen consumption rates and
mitochondrial Ca2þ load, measured by Calcium Green fluores-
cence as in Fig 3D (Fig 7A–D). Although the mitochondrial
homeostasis was normalized, relative ATP levels in the KO-M1þ
cells remained lower than in WT cells (Fig 7E). There was
also less than complete rescue of ER homeostasis, presumably
due to the incomplete replenishment of Miner1 protein levels.
The ER Ca2þ content of the KO-M1þ rescue cells was
significantly elevated compared to KO; however, the level
was not as great as that in WT cells, although not statistically
different from WT (Fig 7F). Indicators of ER stress revealed a
partial rescue, consistent with modest rescue of Miner1 protein
levels. There was a reduction of CHOP protein in the KO-M1þ
cells, but mRNA levels of Bip, CHOP and tXBP1 remained
elevated (Fig 7A,G).DISCUSSION
Wolfram Syndrome was long thought to be a disease of reduced
ATP supply, suggesting mitochondrial dysfunction. This view
was based in part on bioenergetic deficits detected in patients
with this disease. In addition, the tissues affected tend to beEMBO Mol Med (2013) 5, 904–918
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Figure 6. Anti-oxidant treatment mitigates stresses induced by Miner1 deficiency. Source data is available for this figure in the Supporting Information.
A,B. Western blot analysis of whole cell lysates from wildtype (WT) and Miner1 knockout (KO) MEFs with and without 5mM NAC for 48h (15mg protein).
C. Quantitation of anti-cytochrome c immunofluorescent analysis of reticular or punctate mitochondrial morphology. WT and KO MEFs were untreated or
treated with 5mM NAC for 48 h. (n¼ 3 experiments. 80–200 cells scored per experiment. Reticular and punctate morphology % compared by ANOVA
(asterisks denote p< 0.0001, WT reticular> KO reticular, WT punctate< KO punctate, NAC treated WT & KO samples do not differ from WT untreated).
D. Representative Seahorse experiment of OCR (2 106 cells) of WT and KO MEFs that were untreated or treated with 5mM NAC for 48 h prior to the
experiment.those with high energetic demands (Bundey et al, 1992). The
data presented here suggest that the metabolic dysfunction in
WFS2 arises not from a primary mitochondrial defect, but as an
indirect consequence of altered Ca2þ homeostasis at the ER
caused by an alteration of the sulphydryl redox status. We and
others have previously demonstrated that a recombinant
CDGSH domain protein expressed in Escherichia coli is redox
active in vitro (Wiley et al, 2007b). However, data supporting a
redox role for Miner1 in cells has been lacking. In the current
study, we have established the ability of Miner1 to influence
the general redox status in the cell. Miner1 deficient cells
displayed changes in NADþ/NADH ratio, NO production,
GSH/GSSG ratio, protein glutathionylation and oxidation of
sulphydryl groups, including those in CX5R phosphatases. We
found that Miner1 KO MEFs have a more oxidized cytoplasmic
environment and show signs of oxidative stress. The orientation
of the Miner1 CDGSH domain on the cytoplasmic face of the
ER is consistent with a role in regulating cytoplasmic redox
status, and Miner1 KO cells exhibit a general increase inEMBO Mol Med (2013) 5, 904–918 sulphydryl oxidation. The catalytic Cys of the PTP CX5R
family of phosphatases is exquisitely sensitive to sulphydryl
oxidation, resulting in inactivation of the enzymes. Thus, these
phosphatases can be viewed as protein sentinels reflecting
the cellular redox status. The increase in oxidation of catalytic
Cys in phosphatases detected in the mutant MEFs is likely
to have wide-ranging effects on signalling by reversible
phosphorylation.
In addition to redox regulation of phosphatase activity, the
oxidative environment of the Miner1 KO MEFs could lead to
oxidation of regulatory cysteines on ER Ca2þ transporters and
channels. Oxidative modifications of ER Ca2þ transporters have
been shown to affect transport activity and lead to a decrease in
Ca2þ in the ER lumen, resulting from alteration of the activity of
SERCA and increased leak via RyR or IP3 receptors (Sammels
et al, 2010). We observed an increase in SERCA2 glutathionyla-
tion in Miner1 deficient cells, suggesting that the decrease in ER
Ca2þ levels may be caused by changes in SERCA2 transport
activity. Oxidation of IP3 receptors may also contribute to the2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 913
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Figure 7. Characterization of Miner1 re-
expression in KO cells. Miner1 wildtype (WT) and
Miner1 knockout (KO) MEF cell lines, including KO
(Miner1/) MEFs exogenously re-expressing Miner1
(KO-M1þ).
A. Western blot analysis of cell extracts (30mg
protein).
B. Characterization of mitochondrial morphology,
as in Fig 6C. (ANOVA, n¼3 experiments. 80–200
cells scored per experiment (asterisk denotes
p<0.0001, WT punctate< KO punctate; KO/M1
punctate does not differ from WT).
C. Oxygen consumption rates (OCR) were measured
in a Seahorse XF24. Basal and maximal FCCP-
stimulated rates relative to WT basal are shown.
(t-test, n¼6, asterisk denotes p<0.0001, WT
basal<KO basal, WT FCCP<KO FCCP; KO/M1
values do not differ from WT).
D. Mitochondrial Ca2þ measured using Calcium
Green 5N fluorescence. Permeabilized cells were
assayed for total and mitochondrial Ca2þ as in Fig
3D. Values reported are raw Ca2þ measurements.
Average contaminating Ca2þ was 9.52 nmol.
(ANOVA, WT & KO, n¼5; KO-M1þ, n¼3; WT
mito<KO mito, p¼ 0.035, KO/M1 values do not
differ from WT).
E. ATP levels relative to cell number (cps/RFU). KO
and KO-M1þ relative to WT (ANOVA, n¼ 3).
WT>KO (p¼0.0275), WT>KO-M1þ
(p¼ 0.0312).
F. ER Ca2þ release after treatment with 2mM Tg,
expressed as peak responses (Ca2þ – basal Ca2þ)
(ANOVA, n¼ 3) WT> KO (p¼ 0.0004), KO-
M1þ>KO (p¼ 0.0087).
G. qRT-PCR analysis of ER stress markers. Bip, CHOP,
and total XBP1 expression were monitored
(ANOVA, n¼ 3). Bip: WT<KO & KO-M1þ
(p< 0.0001); CHOP: WT<KO (p¼ 0.0005),
WT<KO-M1þ (p¼ 0.0023), KO-M1þ< KO
(p¼ 0.0486); tXBP1: WT<KO (p¼0.0002),
WT<KO-M1þ (p¼ 0.0085).
914Ca2þ dysregulation observed in the Miner1 KO cells. As a redox-
active protein anchored to the ER and enriched in MAMs,
Miner1 is in a prime location to directly interact with these
transporters and keep them in a reduced state.
Because many of the folding chaperones in the ER are Ca2þ-
dependent, decreased ER Ca2þ content has been linked to ER
stress and induction of the UPR. We found that MEFs derived
from Miner1 KO mice also display the hallmark signs of ER
stress/UPR. Miner1-deficient MEFs exhibit elevated levels of the
folding chaperone Bip and the pro-apoptotic protein CHOP, as
well as an expanded ER network.
Enhanced Ca2þ leak from the ER as a result of oxidative
protein modification can explain the increased mitochondrial
Ca2þ load that we observed in Miner1 KO cells and the increase
in dephosphorylated PDH. Oxidation of RyR Ca2þ channels have
been associated with increased Ca2þ leak from the ER, increased
mitochondrial Ca2þ loading and increased muscle wasting 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.in mice (Andersson et al, 2011). Sarcopenia was also observed
in the Miner1 KO mice (Chen et al, 2009). Enhanced ER Ca2þ
leak would also predict the elevated ADP/ATP ratio and the
enhanced rate of ATP utilization we observed in the rates
of endogenous O2 consumption (Norris et al, 2010). These
findings, along with a decreased growth rate, are consistent with
an underlying mechanism of enhanced futile Ca2þ cycling.
There is precedent for altered mitochondrial Ca2þ loading,
morphology and function caused by changes in ER protein
function. Expression of a truncated isoform of SERCA1 results
in ER Ca2þ leak, mitochondrial Ca2þ loading, changes in
mitochondrial morphology and increased ER-mitochondrial
contacts (Chami et al, 2008). Similarly, mutations in presenilin2,
an intramembrane protease that is localized to the ER and
that is linked to the onset of Alzheimer’s Disease, influences
ER-mitochondrial Ca2þ cross-talk and physical contacts
(Zampese et al, 2011). Consistent with these paradigms ofEMBO Mol Med (2013) 5, 904–918
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MEFs have altered mitochondrial structure. Surprisingly,
mitochondria isolated from Miner1 KO MEFs demonstrated
much higher respiratory capacity than WT mitochondria, in
contrast to the mitochondria isolated from muscle of Miner1 KO
mice, which showed virtually no ADP-stimulated respiration
(Chen et al, 2009). It is possible that immortalization of
the MEFs in culture promotes tolerance and adaptation to the
mitochondrial Ca2þ loading and elevated ROS, perhaps via a
compensatory increase in cristae area and expression of ETC
components. We predict that an electrically excitable cell
type, such as a neuron or myocyte, would not tolerate this
form of Ca2þ dysregulation and would be more likely to suffer
from mitochondrial dysfunction. The phenotype of a recently
reported secondmousemodel ofMiner1 deficiency is significantly
milder than the mouse established by Chen and colleagues (Chen
et al, 2009) (the source of our fibroblasts) and lacks features
present in the human disease (Chang et al, 2012). However, the
increase in cristae density that we observe in the fibroblasts is
recapitulated in skeletal muscle myocytes of the mouse
established by Chang and coworkers (Chang et al, 2012).
Wolfram Syndrome patients present with diabetes mellitus
and diabetes insipidus, which result from compromised
production of insulin by the pancreas and of vasopressin by
the pituitary, respectively. Both of these are secretory organs
that place a tremendous demand on the ER for protein folding.
The chronic ER stress created by Miner1 deletion is likely to
overwhelm the protein folding and secretory capacity of these
organs in the short term, and ultimately lead to organ failure.
The blindness and deafness observed in Wolfram Syndrome is
of neuronal origin, and the chronic oxidative stress, mitochon-
drial Ca2þ loading and lower ATP levels that we observed could
lead to chronic dysfunction or death of electrically excitable
cells. The sarcopenia observed in Miner1 KO mice could reflect
low ER Ca2þ levels in muscle. Lastly, oxidative stress has been
correlated with both aging and the diabetic state (Giacco &
Brownlee, 2010; Haigis & Yankner, 2010). Thus, our cell culture
model has enabled us to develop a mechanistic model for the
manifestations of Wolfram Syndrome observed in human
patients and knockout mice (Supporting Information Fig S7).
Our studies form the basis of a new paradigm for the
function of Miner1 and the etiology of Wolfram Syndrome. We
conclude that Miner1 is a redox protein that resides in the ER
and that regulates the UPR and mitochondrial function.
Consequently, our data suggests that the defects observed in
Miner1 MEFs stem from oxidative stress, which can be
mitigated by treatment with anti-oxidants. Indeed, application
of the sulphydryl anti-oxidant NAC reversed many of the
mitochondrial and ER stress-related anomalies observed in
the Miner1 KO cells, hence anti-oxidant treatment represents
a potentially promising therapeutic strategy for treating this
currently incurable disease.MATERIALS AND METHODS
Further details can be found in Supporting Information.EMBO Mol Med (2013) 5, 904–918 Cell culture and reagents
Miner1 (Cisd2) WT and KO MEFs were immortalized using a retroviral
vector expressing Tantigen. Construction of cell lines to modulate levels
of Miner1 and mitoNEET are described in detail in Supporting
Information Methods. Transient transfections of HEK293T and COS7
cells were performed using Fugene (Roche). Cells were harvested for
microsomal isolation or xed for immunouorescent staining 24–48h
post-transfection. Unless stated, all chemicals were from Sigma–
Aldrich.
Tissue/cell fractionation and manipulation
Mitochondria, MAM, ER and cytosolic (soluble) fractions were prepared
from rat livers and analysed by Western blot as described (Wieckowski
et al, 2009). Microsomal ER fractions were prepared from fresh rat
livers and subjected to high salt and high pH washes, followed by
trypsinolysis as previously described (Wiley et al, 2007a).
Western blots and immunofluorescence analysis
In general, equivalent amounts of protein were loaded for SDS-PAGE
and Western blotting. MitoTracker Red and immunostaining was
performed as described (Wiley et al, 2007a). Cells were imaged with a
Leica DMR microscope and a Hamamatsu camera. Images were
processed with OpenLab Software.
Real-time PCR and statistical analyses
mRNA was isolated using the RNeasy miniprep kit (Qiagen). cDNA
synthesis was performed using the iScript kit (Bio-Rad), and qRT-PCR
performed using Syber Green PCR Master Mix (ABI). See Supporting
Information for primer sequences and further details. Students t-tests
and ANOVAs with Tukey post-tests were performed using Prism Graph
Pad Software. n-values represent number of separate experiments.
Values of p<0.05 () were considered statistically signicant [p<0.01
(); p<0.001 ()]. All data are presented as mean standard error of
the mean (S.E.M.) unless otherwise specied.
Ca2R assays
ER Ca2þ storeswere quantied following 2mMTg-induced ER Ca2þ release
using Fura2-AM (Invitrogen) and a FLEX-Station (Molecular Devices). ER
Ca2þ release via the IP3 receptorwas triggered by treatmentwith 100mM
histamine.The Ca2þ content of mitochondria and other intracellular Ca2þ
stores was assessed in digitonin-permeablized cells using Calcium Green
5N (Invitrogen) with cells in suspension in a cuvette using the LS-50B
spectrouorometer (Perkin-Elmer). See Supporting Information Fig S3 and
Methods for further details.
Mitochondrial respiration, ATP, cell proliferation and redox
measurements
The Seahorse XF24 Extracellular Flux Analyzer was used to determine
OCR as a measure of mitochondrial respiratory function in whole cells
and isolated mitochondria. OCR replicates varied from 3 to 6 per
experiment. ADP/ATP ratios were determined using the uorescent
ApoSensor ADP/ATP Ratio kit (BioVision). Cell proliferation was assessed
by EdU incorporation into DNA using the Click-iT EdU Imaging kit
(Invitrogen). Relative ATP levels were also assessed using CellTiter Glo
(Promega). NADþ/NADH ratios were measured using an NAD/NADH
Assay Kit (Abcam). ROS was imaged in live cells using the Image-iT
LIVE Green ROS detection kit (carboxy-H2DCFDA) (Molecular Probes).2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 915
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The paper explained
PROBLEM:
Wolfram Syndrome (DIDMOAD) is an incurable disease
characterized by a range of endocrine and neurological
symptoms, including diabetes insipidus, diabetes mellitus,
blindness due to optic atrophy and sensorineural deafness.
Mutations in the genes encoding Wolframin (an endoplasmic
reticulum protein involved in ion channel activity and the
unfolded protein response) or Miner1 (a 2Fe-2S cluster-
containing protein) lead to the development of DIDMOAD. Full
understanding of DIDMOAD is hindered by limited insight into
the role of Miner1 in the cell.
RESULTS:
We used fibroblasts immortalized from WT and Miner1 KO
mouse embryos to elucidate the cellular processes impacted by
Miner1. Deletion of Miner1 results in a more oxidized
intracellular milieu, and this is associated with ER stress and the
unfolded protein response, profound ER and mitochondrial Ca2þ
dysregulation, and altered mitochondrial structure and function.
Importantly, treatmentwith the sulphydryl anti-oxidantN-acetyl
cysteine ameliorates many of the mitochondrial and ER-stress
related anomalies observed in the Miner1 KO cells.
IMPACT:
Our studies form the basis of a paradigm for the function of
Miner1 and provide novel mechanistic insights into the under-
lying pathology of DIDMOAD. These experiments strongly suggest
that oxidative stress lies at the root of the ER and mitochondrial
changes caused by Miner1 deficiency, and importantly that
sulphydryl anti-oxidant treatment could be a rational thera-
peutic approach for treating this syndrome.
916Nitric oxide (NO) was imaged using the NO-specic uorescent probe
(NO–ON) (StremChemicals). Released nitrite, a stable oxidation product
of NO, was measured using the Griess Assay; media was collected from
WT and KO MEFs 2 days post-conuence and assayed. Total reduced
thiols were measured using the Fluoro Thiol Detection Kit (Cell
Technology, Inc.). GSH/GSSG ratios were determined using the
Glutathione Assay kit (Cayman Chemical); both were normalized to
protein concentration. All assays were performed following the
manufacturers’ instructions. For oxidized PTP blots, cell lysates were
analysed by SDS-PAGE with an antibody recognizing the sulphonic acid
oxidation state of the active site cysteine (R&D Systems). The oxidation
state of the catalytic Cys in various PTPs was measured by mass
spectrometry as described (Karisch et al, 2011). See Supporting
Information Methods for further details.
EM and morphometric analysis
Cell growth, preparation and EM analysis were as previously described;
ImageJ (NIH) was used to perform morphometric analysis of
mitochondrial volume and cristae/OMM surface area as previously
described (Zhang et al, 2011).Author contributions
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